cubePRO vs IQVIA Scribe
Price, ratings, monetisation and update history for both apps, side by side — with what reviewers say about each.
cubePRO
Read full descriptionHide full description
cubePRO enhances patient engagement by enabling them to enter their own clinical trial data directly. Patients can simply answer clinical trial questionnaires anywhere just by using this application and receive notifications informing them when to send their information.
IQVIA Scribe
This application allows patients participating in clinical trials to securely capture and submit data directly from their mobile devices. It provides relevant questionnaires throughout the study duration, amplifying patient voices in research.
- Online/offline data capture
- Patient enrollment notifications
- Study-specific questionnaires
- Secure data submission
- Automated eCOA process
Read full descriptionHide full description
IQVIA Scribe is an online/offline application used to capture data directly from patients enrolled in clinical trials. Patients enrolled in a study using Scribe will receive an enrollment notification via email or text with a link to download the application and instructions used to enroll in the study. Relevant questionnaires will be available for completion throughout the duration of the study ++++Scribe amplifies the patient's voice in clinical research by allowing Clinical Outcomes Assessments to be used in more trials. Whether deploying to smartphones, tablets or the web, our Sculptor visual build and deployment tools help automate the eCOA process, giving absolute transparency and greater control to sponsors and CRO’s.
Screenshots
Verdict
cubePRO and IQVIA Scribe are too close to call on the numbers: across 6 compared parameters — price, update cadence, ads and in-app purchases among them — neither pulls far enough ahead to decide it. What separates them is feature set and interface, not measurable difference.
Scored on Price · Rating · Positive reviews · Number of ratings · Update frequency · Ads · In-app purchases · Monetization · Best chart rank · Devices · Requires iOS
Both are free to download. Neither carries in-app purchases, so what you see is what you pay.
Both ship on a similar rhythm, roughly every 2 months. The most recent releases landed on October 9, 2026 and October 20, 2026 respectively.
| Parameter | cubePRO | IQVIA Scribe |
|---|---|---|
| Price | Free | Free |
| Rating | — | 3.0 (37 ratings) — better |
| Positive reviews | — | 20.0% of reviews |
| Number of ratings | — | 37 — better |
| Update frequency | Every 2 months | Every 2 months |
| Ads | No | No |
| In-app purchases | No | No |
| Monetization | — | Free |
| Devices | iPhone, iPad | iPhone, iPad, iPod — better |
| Requires iOS | 16.0 | 15.5 — better |
| Further details — not scored | ||
| Size | 22 MB | 33 MB |
| Age rating | 4+ | 4+ |
| Developer | (주)씨알에스큐브 | IQVIA RDS INC. |
In-app purchases
cubePRO
No in-app purchases
IQVIA Scribe
No in-app purchases
